YAP1 and posterior cortical atrophy: Furthermore, yes-associated protein 1 (YAP1) overexpression has been shown to contribute to the development of enzalutamide resistance by inducing the acquisition of cancer stemness and activating lipid metabolism in PCa cells 16.